title: Reactive perforating collagenosis during erlotinib therapy.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Yamamoto
mesh_terms: D000368:Aged; D003095:Collagen Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D048909:Diabetes Complications / Q000150:complications; D003875:Drug Eruptions / Q000209:etiology; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride